To Avert a GLP-1 Cost Tsunami, Add Lifestyle Interventions: Learning from Virta Health
Health Populi
JULY 17, 2023
With consumer and prescriber interest in GLP-1 receptor agonist drugs “soaring,” health plan managers have a new source of financial stress and clinical questions on their to-do list. Because of rising costs and the conditions downstream health impacts, Virta noted in the report. . Why diabetes and obesity?
156 
Let's personalize your content